Hollsteen
← MACOM

Cash and equivalents

Balance – as of period end · $M

QuartersFiscal years

$MCash and equivalents · Q1 FY2016: $48.0M · 10-Q 0001193125-16-439832 filed Jan 27, 2016Cash and equivalents · Q2 FY2016: $58.0M · 10-Q 0001193125-16-559543 filed Apr 27, 2016Cash and equivalents · Q3 FY2016: $67.0M · 10-Q 0001493594-16-000007 filed Jul 27, 2016Cash and equivalents · Q4 FY2016: $333M · 10-K 0001493594-16-000016 filed Nov 17, 2016Cash and equivalents · Q1 FY2017: $152M · 10-Q 0001493594-19-000008 filed Feb 6, 2019Cash and equivalents · Q2 FY2017: $113M · 10-Q 0001493594-17-000037 filed Apr 26, 2017Cash and equivalents · Q3 FY2017: $168M · 10-Q 0001493594-17-000046 filed Aug 2, 2017Cash and equivalents · Q4 FY2017: $130M · 10-K 0001493594-17-000055 filed Nov 15, 2017Cash and equivalents · Q1 FY2018: $152M · 10-Q 0001493594-18-000008 filed Feb 7, 2018Cash and equivalents · Q2 FY2018: $163M · 10-Q 0001493594-18-000019 filed May 3, 2018Cash and equivalents · Q3 FY2018: $85.0M · 10-Q 0001493594-18-000026 filed Aug 1, 2018Cash and equivalents · Q4 FY2018: $95.0M · 10-K 0001493594-18-000034 filed Nov 16, 2018Cash and equivalents · Q1 FY2019: $87.0M · 10-Q 0001493594-19-000008 filed Feb 6, 2019Cash and equivalents · Q2 FY2019: $93.0M · 10-Q 0001493594-19-000022 filed May 8, 2019Cash and equivalents · Q3 FY2019: $85.0M · 10-Q 0001493594-19-000051 filed Aug 6, 2019Cash and equivalents · Q4 FY2019: $76.0M · 10-K 0001493594-19-000064 filed Nov 26, 2019Cash and equivalents · Q1 FY2020: $108M · 10-Q 0001493594-20-000017 filed Jan 29, 2020Cash and equivalents · Q2 FY2020: $121M · 10-Q 0001493594-20-000037 filed Apr 30, 2020Cash and equivalents · Q3 FY2020: $132M · 10-Q 0001493594-20-000051 filed Jul 30, 2020Cash and equivalents · Q4 FY2020: $129M · 10-K 0001493594-20-000063 filed Nov 18, 2020Cash and equivalents · Q1 FY2021: $129M · 10-Q 0001493594-21-000014 filed Jan 28, 2021Cash and equivalents · Q2 FY2021: $106M · 10-Q 0001493594-21-000056 filed Apr 29, 2021Cash and equivalents · Q3 FY2021: $144M · 10-Q 0001493594-21-000072 filed Jul 29, 2021Cash and equivalents · Q4 FY2021: $157M · 10-K 0001493594-21-000079 filed Nov 15, 2021Cash and equivalents · Q1 FY2022: $273M · 10-Q 0001493594-22-000011 filed Jan 27, 2022Cash and equivalents · Q2 FY2022: $128M · 10-Q 0001493594-22-000025 filed Apr 28, 2022Cash and equivalents · Q3 FY2022: $132M · 10-Q 0001493594-22-000037 filed Jul 28, 2022Cash and equivalents · Q4 FY2022: $120M · 10-K 0001493594-22-000047 filed Nov 14, 2022Cash and equivalents · Q1 FY2023: $126M · 10-Q 0001493594-23-000035 filed Feb 2, 2023Cash and equivalents · Q2 FY2023: $137M · 10-Q 0001493594-23-000046 filed May 4, 2023Cash and equivalents · Q3 FY2023: $122M · 10-Q 0001493594-23-000057 filed Aug 3, 2023Cash and equivalents · Q4 FY2023: $174M · 10-K 0001493594-23-000081 filed Nov 13, 2023Cash and equivalents · Q1 FY2024: $164M · 10-Q 0001493594-24-000028 filed Feb 1, 2024Cash and equivalents · Q2 FY2024: $115M · 10-Q 0001493594-24-000040 filed May 2, 2024Cash and equivalents · Q3 FY2024: $117M · 10-Q 0001493594-24-000052 filed Aug 1, 2024Cash and equivalents · Q4 FY2024: $147M · 10-K 0001493594-24-000060 filed Nov 12, 2024Cash and equivalents · Q1 FY2025: $233M · 10-Q 0001493594-25-000020 filed Feb 6, 2025Cash and equivalents · Q2 FY2025: $111M · 10-Q 0001493594-25-000029 filed May 8, 2025Cash and equivalents · Q3 FY2025: $125M · 10-Q 0001493594-25-000038 filed Aug 7, 2025Cash and equivalents · Q4 FY2025: $112M · 10-K 0001493594-25-000054 filed Nov 14, 2025Cash and equivalents · Q1 FY2026: $120M · 10-Q 0001493594-26-000019 filed Feb 5, 2026Cash and equivalents · Q2 FY2026: $99.0M · 10-Q 0001493594-26-000028 filed May 7, 2026Cash and equivalents · Q3 FY2026: $90.0M · 10-Q 0001493594-26-000038 filed Aug 6, 20261289048333Q1 FY2016Q3 FY2026Q2 FY2022
$MCash and equivalents · Q2 FY2021: $106M · 10-Q 0001493594-21-000056 filed Apr 29, 2021Cash and equivalents · Q3 FY2021: $144M · 10-Q 0001493594-21-000072 filed Jul 29, 2021Cash and equivalents · Q4 FY2021: $157M · 10-K 0001493594-21-000079 filed Nov 15, 2021Cash and equivalents · Q1 FY2022: $273M · 10-Q 0001493594-22-000011 filed Jan 27, 2022Cash and equivalents · Q2 FY2022: $128M · 10-Q 0001493594-22-000025 filed Apr 28, 2022Cash and equivalents · Q3 FY2022: $132M · 10-Q 0001493594-22-000037 filed Jul 28, 2022Cash and equivalents · Q4 FY2022: $120M · 10-K 0001493594-22-000047 filed Nov 14, 2022Cash and equivalents · Q1 FY2023: $126M · 10-Q 0001493594-23-000035 filed Feb 2, 2023128126106273Q2 FY2021Q1 FY2023Q2 FY2022
Q2 FY2022
128$M
All values (43)
PeriodValue ($M)Status
Q3 FY202690reported
Q2 FY202699reported
Q1 FY2026120reported
Q4 FY2025112reported
Q3 FY2025125reported
Q2 FY2025111reported
Q1 FY2025233reported
Q4 FY2024147reported
Q3 FY2024117reported
Q2 FY2024115reported
Q1 FY2024164reported
Q4 FY2023174reported
Q3 FY2023122reported
Q2 FY2023137reported
Q1 FY2023126reported
Q4 FY2022120reported
Q3 FY2022132reported
Q2 FY2022128reported
Q1 FY2022273reported
Q4 FY2021157reported
Q3 FY2021144reported
Q2 FY2021106reported
Q1 FY2021129reported
Q4 FY2020129reported
Q3 FY2020132reported
Q2 FY2020121reported
Q1 FY2020108reported
Q4 FY201976reported
Q3 FY201985reported
Q2 FY201993reported
Q1 FY201987reported
Q4 FY201895reported
Q3 FY201885reported
Q2 FY2018163reported
Q1 FY2018152reported
Q4 FY2017130reported
Q3 FY2017168reported
Q2 FY2017113reported
Q1 FY2017152reported
Q4 FY2016333reported
Q3 FY201667reported
Q2 FY201658reported
Q1 FY201648reported

CSV with all sources · Technical ID: cash

More metrics for MACOM

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Operating income by segment

Sources & calculation
Value
$128M
Period
Q2 FY2022, ended Apr 1, 2022 · as of Apr 1, 2022 (balance as of date, not a sum)
Source
10-Q, filed Apr 28, 2022 · 0001493594-22-000025
Location
us-gaap:CashAndCashEquivalentsAtCarryingValue
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$128MApr 28, 202210-Q 0001493594-22-000025reported · confidence 1. · current